A detailed history of Ubs Group Ag transactions in Apyx Medical Corp stock. As of the latest transaction made, Ubs Group Ag holds 705 shares of APYX stock, worth $1,106. This represents 0.0% of its overall portfolio holdings.

Number of Shares
705
Previous 1,273 44.62%
Holding current value
$1,106
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.01 - $1.46 $573 - $829
-568 Reduced 44.62%
705 $0
Q2 2024

Aug 13, 2024

BUY
$1.26 - $1.66 $968 - $1,276
769 Added 152.58%
1,273 $1,000
Q1 2024

May 13, 2024

SELL
$1.25 - $2.71 $4,720 - $10,232
-3,776 Reduced 88.22%
504 $0
Q4 2023

Feb 09, 2024

BUY
$1.49 - $3.25 $5,781 - $12,610
3,880 Added 970.0%
4,280 $11,000
Q2 2023

Aug 11, 2023

SELL
$2.75 - $7.59 $500 - $1,381
-182 Reduced 31.27%
400 $2,000
Q1 2023

May 12, 2023

SELL
$2.45 - $3.59 $85 - $125
-35 Reduced 5.67%
582 $1,000
Q4 2022

Feb 08, 2023

SELL
$1.4 - $5.02 $1.24 Million - $4.46 Million
-888,427 Reduced 99.93%
617 $1,000
Q3 2022

Nov 10, 2022

BUY
$4.49 - $10.83 $33,369 - $80,488
7,432 Added 0.84%
889,044 $3.99 Million
Q2 2022

Aug 10, 2022

BUY
$3.11 - $7.5 $2.74 Million - $6.61 Million
881,612 New
881,612 $5.17 Million
Q1 2022

May 16, 2022

SELL
$5.87 - $13.13 $17,610 - $39,390
-3,000 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$4.85 - $8.19 $9,700 - $16,379
-2,000 Reduced 40.0%
3,000 $22,000
Q3 2020

Nov 12, 2020

SELL
$4.38 - $5.47 $4,380 - $5,470
-1,000 Reduced 16.67%
5,000 $24,000
Q1 2020

May 01, 2020

SELL
$3.24 - $8.51 $12,960 - $34,040
-4,000 Reduced 40.0%
6,000 $22,000
Q4 2019

Feb 14, 2020

BUY
$6.29 - $8.46 $25,160 - $33,840
4,000 Added 66.67%
10,000 $85,000
Q3 2019

Nov 14, 2019

SELL
$6.3 - $7.9 $12,600 - $15,800
-2,000 Reduced 25.0%
6,000 $41,000
Q1 2019

May 14, 2019

BUY
$6.31 - $8.75 $50,480 - $70,000
8,000 New
8,000 $50,000

Others Institutions Holding APYX

About Apyx Medical Corp


  • Ticker APYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,573,000
  • Market Cap $54.3M
  • Description
  • Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ab...
More about APYX
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.